Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

58.27
+1.172.05%
Post-market: 58.270.00000.00%19:38 EST
Volume:3.13M
Turnover:182.08M
Market Cap:9.08B
PE:119.71
High:58.87
Open:57.83
Low:57.03
Close:57.10
52wk High:79.28
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:1.52
T/O Rate:2.02%
Dividend:0.32
Dividend Rate:0.55%
EPS(TTM):0.4867
EPS(LYR):0.4657
ROE:3.80%
ROA:6.25%
PB:4.62
PE(LYR):125.11

Loading ...

Bio-Techne Corp Exec Says Co Anticipates Organic Growth Will Remain in a Low Single Digit Range Until the Current Headwinds Begin to Subside - Conf Call

THOMSON REUTERS
·
Aug 06

Bio-Techne Corp Exec Says Customers Are Actually Behaving More Conservative Than Even the Worst Case Scenario - Conf Call

THOMSON REUTERS
·
Aug 06

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Reuters
·
Aug 06

Bio-Techne Q4 Adj. EPS $0.53 Beats $0.50 Estimate, Sales $316.964M Beat $316.004M Estimate

Benzinga
·
Aug 06

Bio-Techne Q4 Operating Expenses USD 222.672 Million

THOMSON REUTERS
·
Aug 06

BRIEF-Bio-Techne Announces Exosome Diagnostics Divestiture

Reuters
·
Aug 06

Bio-Techne Corporation Announces Divestiture of Exosome Diagnostics to Mdxhealth in Strategic Move

Reuters
·
Aug 06

Bio-Techne Corp - to Receive $5 Mln in Mdxh Stock Combined With Future Considerations

THOMSON REUTERS
·
Aug 06

Bio-Techne Corp - Under the Terms of Agreement, Bio-Techne Will Receive $5 Million in Mdxh Stock Combined With Future Considerations

THOMSON REUTERS
·
Aug 06

MDxHealth Reports 20% Increase in Q2 Revenue, Achieves Positive Adjusted EBITDA of $1.4 Million, and Reduces Net Loss by 36%

Reuters
·
Aug 06

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

GlobeNewswire
·
Aug 06

YSX TECH. CO. 2025 Total Revenue $71.5M, Up 22%

Benzinga
·
Aug 01

YSX TECH. CO., LTD Announces Financial Results for Fiscal Year 2025

GlobeNewswire
·
Aug 01

Baird Adjusts Price Target on Bio-Techne to $58 From $51

MT Newswires Live
·
Aug 01

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jul 30

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 23

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 18

Bio-Techne Corporation to Announce Fourth Quarter and Fiscal 2025 Financial Results

Reuters
·
Jul 17

Bio-Techne Corporation Announces Strategic Partnership with Spear Bio to Advance Biomarker Detection in Neurodegenerative Disease Research

Reuters
·
Jul 15

Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jul 15